ALX Oncology Holdings (ALXO) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -11.9 | 0.00 | 0.00 | -0.71 | -0.72 | -1.39 | |||
| Changes by years, y/y, % | -87% | -100% | +1% | -61.9% | |||||
ALX Oncology Holdings. P/FCF
ALX Oncology Holdings. P/FCF, changes, %
ALX Oncology Holdings (ALXO) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -0.30 | -0.21 | -1.01 | -0.73 | -1.39 | -1.39 | ||
| Changes by years, y/y, % | +36% | +1% | +357% | |||||
| Changes by quarters, q/q, % | -58% | -31% | +380% | -28% | +92% | |||